Hits, Fhits and Nits: beyond enzymatic function.
暂无分享,去创建一个
Jin Sun | Hidetaka Shibata | K. Huebner | T. Druck | Kay Huebner | Joshua C Saldivar | Teresa Druck | J. Saldivar | Jin Sun | Hidetaka Shibata
[1] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[2] A. McLennan,et al. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. , 2000, Cancer research.
[3] K. Huebner,et al. The histidine triad superfamily of nucleotide‐binding proteins , 1999, Journal of cellular physiology.
[4] C. Croce,et al. Fragile gene product, Fhit, in oxidative and replicative stress responses , 2009, Cancer science.
[5] J. Sun,et al. Nit1 and Fhit tumor suppressor activities are additive , 2009, Journal of cellular biochemistry.
[6] L. D. Barnes,et al. Adenosine Monophosphoramidase Activity of Hint and Hnt1 Supports Function of Kin28, Ccl1, and Tfb3* 210 , 2002, The Journal of Biological Chemistry.
[7] K. Caldecott,et al. Short-patch single-strand break repair in ataxia oculomotor apraxia-1. , 2009, Biochemical Society transactions.
[8] Haiyang Li,et al. Hint1 is a haplo-insufficient tumor suppressor in mice , 2006, Oncogene.
[9] K. Huebner,et al. Involvement of the Fhit gene in the ionizing radiation‐activated ATR/CHK1 pathway , 2005, Journal of cellular physiology.
[10] D. Iliopoulos,et al. Biological Functions of Mammalian Nit1, the Counterpart of the Invertebrate NitFhit Rosetta Stone Protein, a Possible Tumor Suppressor* , 2006, Journal of Biological Chemistry.
[11] L. D. Barnes,et al. The role of the FHIT/FRA3B locus in cancer. , 1998, Annual review of genetics.
[12] K. Caldecott,et al. Defective DNA Ligation during Short-Patch Single-Strand Break Repair in Ataxia Oculomotor Apraxia 1 , 2008, Molecular and Cellular Biology.
[13] Y. Pekarsky,et al. Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers , 2000, Current Biology.
[14] L. D. Barnes,et al. The Tumor Suppressor Protein Fhit , 1999, The Journal of Biological Chemistry.
[15] C. Croce,et al. Fhit modulates the DNA damage checkpoint response. , 2006, Cancer research.
[16] L. D. Barnes,et al. Correlation of Fragile Histidine Triad (Fhit) Protein Structural Features with Effector Interactions and Biological Functions* , 2009, Journal of Biological Chemistry.
[17] T. Gibson,et al. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin , 2001, Nature Genetics.
[18] Y. Pekarsky,et al. Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] L. D. Barnes,et al. Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. , 1995, The Biochemical journal.
[20] J. Harris,et al. Aprataxin Forms a Discrete Branch in the HIT (Histidine Triad) Superfamily of Proteins with Both DNA/RNA Binding and Nucleotide Hydrolase Activities* , 2006, Journal of Biological Chemistry.
[21] H. Ishii,et al. Molecular parameters of genome instability: Roles of fragile genes at common fragile sites , 2008, Journal of cellular biochemistry.
[22] C. Lima,et al. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Huebner,et al. Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination. , 2009, Biochimie.
[24] C. Croce,et al. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. , 2001, JAMA.
[25] O. Huber,et al. The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity , 2007, Proceedings of the National Academy of Sciences.
[26] S. Sugano,et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene , 2001, Nature Genetics.
[27] H. Ishii,et al. A Fhit-ing Role in the DNA Damage Checkpoint Response , 2007, Cell cycle.
[28] J. Minna,et al. Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.
[29] C. Croce,et al. The tumor spectrum in FHIT-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Weinstein,et al. Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src* , 2009, Journal of Biological Chemistry.
[31] Charles Brenner,et al. Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. , 2002, Biochemistry.
[32] Haiyang Li,et al. The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage , 2008, The Journal of cell biology.
[33] O. Huber,et al. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF–β-catenin-mediated transcription , 2005, Journal of Cell Science.
[34] S. Warren,et al. Replication stress induces tumor-like microdeletions in FHIT/FRA3B , 2008, Proceedings of the National Academy of Sciences.
[35] C. Brenner,et al. The nitrilase superfamily: classification, structure and function , 2001, Genome Biology.
[36] M. L. Le Beau,et al. Common fragile sites are characterized by histone hypoacetylation , 2009, Human molecular genetics.
[37] T. Chou,et al. Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. , 2007, Molecular pharmaceutics.
[38] Arthur J. L. Cooper,et al. Assay and purification of omega-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the alpha-keto acid analogues of glutamine and asparagine. , 2009, Analytical biochemistry.
[39] L. D. Barnes,et al. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Croce,et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Paterson,et al. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. , 2000 .
[42] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Stevens,et al. Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. , 2008, Biochemistry.
[44] C. Croce,et al. Fhit Interaction with Ferredoxin Reductase Triggers Generation of Reactive Oxygen Species and Apoptosis of Cancer Cells* , 2008, Journal of Biological Chemistry.
[45] M. Veiga-da-Cunha,et al. Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. , 2009, Biochimie.
[46] K. Huebner,et al. Pathology and biology associated with the fragile FHIT gene and gene product , 2010, Journal of cellular biochemistry.
[47] L. D. Barnes,et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.
[48] S. Thorgeirsson,et al. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. , 2006, Gastroenterology.